Cationic Lipid with Disulfide Linkage for Nucleic Acid Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cationic lipids used for nucleic acid delivery lack sufficient intracellular dynamics, such as uptake efficiency, endosomal escape, and nucleic acid dissociation, which limits their effectiveness in delivering nucleic acids into cells.
Innovation Solution
A novel cationic lipid with a structure that includes an aromatic ring introduced near the lipid moiety, linked by a disulfide bond, which adjusts the pKa of the lipid membrane structure for enhanced endosomal escape and incorporates a disulfide bond for intracellular cleavage and nucleic acid release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the amount of amino groups in cationic lipid is increased to promote uptake into cells, then cellular uptake efficiency is improved, but nucleic acid delivery efficiency deteriorates because dissociation of nucleic acid from the carrier is suppressed
Solution Approach 1:
The cationic lipid molecule is segmented into distinct functional domains: a hydrophobic lipid tail for membrane interaction, a cationic ammonium group for electrostatic binding to nucleic acid, and a phenolic hydroxyl group for hydrogen bonding. This segmentation allows each domain to independently contribute to its specific function while maintaining overall balance, resolving the contradiction between uptake efficiency and delivery efficiency.
Solution Approach 2:
The lipid structure incorporates localized functional groups with specific properties: the phenolic hydroxyl group at a specific position provides hydrogen bonding capability that enhances nucleic acid binding, while the cationic ammonium group provides electrostatic interaction. This local quality differentiation enables the lipid to simultaneously optimize both cellular uptake and nucleic acid delivery without the trade-off imposed by uniform amino group increase.
2Productivity
If the pKa of lipid membrane structure is adjusted for endosomal escape, then endosomal escape efficiency is improved, but not all structures with appropriate pKa show high nucleic acid delivery efficiency
Solution Approach 1:
The invention optimizes specific molecular parameters of the cationic lipid: the phenolic hydroxyl group position and the carbon chain length of the lipid tail are carefully controlled to achieve the desired pKa range (6.5-7.5) for the lipid membrane structure. This precise parameter control ensures both endosomal escape capability and high nucleic acid delivery efficiency, resolving the inconsistency where not all pKa-adjusted structures perform well.
3Productivity
If membrane fusion capacity is improved for endosomal escape, then endosomal escape efficiency is improved, but the structural requirements for membrane fusion are not clearly defined in prior art
Solution Approach 1:
The invention establishes clear structural parameters that govern membrane fusion capacity: the phenolic hydroxyl group at a specific position and the cationic ammonium group with defined carbon chain length. These parameter specifications provide a clear design framework for achieving membrane fusion without requiring complex structural modifications, thus improving endosomal escape while managing design complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel cationic lipid formulation achieves high membrane fusion capacity and endosomal escape efficiency, leading to enhanced nucleic acid delivery into the cytoplasm, improved stability in blood, and targeted accumulation in tumor sites.
Implementation Method 1
the amine moiety showing cationicity and a polyanion nucleic acid electrostatically interact to form a positively-charged liposome or lipid membrane structure
Implementation Method 2
incorporates a disulfide bond for intracellular cleavage and nucleic acid release
Implementation Method 3
high membrane fusion capacity in the endosomal environment, shows high endosomal escape efficiency
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
Provided are a cationic lipid having improved intracellular kinetics, a lipid membrane structure containing same, and use thereof. A cationic lipid represented by the formula (1) (in the formula (1), R1a and R1b are each independently an alkylene group having 1 - 6 carbon atoms, Xa and Xb are each independently a non-cyclic alkyl tertiary amino group having 1 - 6 carbon atoms and one tertiary amino group, or a cyclic alkylene tertiary amino group having 2 - 5 carbon atoms and 1 - 2 tertiary amino groups, R2a and R2b are each independently an alkylene group or an oxydialkylene group each having not more than 8 carbon atoms, Ya and Yb are each independently an ester bond, an amide bond, a carbamate bond, an ether bond or a urea bond, Za and Zb are each independently a divalent group derived from an aromatic compound having 3 - 16 carbon atoms and at least one aromatic ring, and optionally having a hetero atom, and R3a and R3b are each independently a residue derived from a reaction product of a liposoluble vitamin having a hydroxyl group, and succinic anhydride or glutaric anhydride, or a residue derived from a reaction product of a sterol derivative having a hydroxyl group, and succinic anhydride or glutaric anhydride, or an aliphatic hydrocarbon group having 12 - 22 carbon atoms).